Robert Harris Schwartz - May 17, 2022 Form 4 Insider Report for Anterix Inc. (ATEX)

Role
President and CEO, Director
Signature
/s/ Gena Ashe, Attorney-in-Fact
Stock symbol
ATEX
Transactions as of
May 17, 2022
Transactions value $
$0
Form type
4
Date filed
5/19/2022, 04:22 PM
Previous filing
Sep 20, 2021
Next filing
Jun 1, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATEX Stock Option (Right to Buy) Award $0 +122K $0.00 122K May 17, 2022 Common Stock 122K $49.39 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the option shares vest and become exercisable on May 17, 2023, with the remaining option shares vesting in 3 equal annual installments thereafter.

Remarks:

Exhibit 24 - Power of Attorney